Remove Advocacy Remove Clinical Trials Remove Epilepsy Remove Pharmaceutical
article thumbnail

Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting

Cannabis Law Report

.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Phase 2, Placebo-Controlled Clinical Study of Oral Ganaxolone in PCDH19-Clustering Epilepsy (the Violet Study). About Marinus Pharmaceuticals. Date and Time: Monday, Dec.

article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “Combining Social Sciences and Pharmacology to Make a Positive Social Impact in Cannabis” . School: University of Maryland.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

And because CBD doesn’t get you high, it was easy to miss; hardly anyone outside of pharmaceutical companies and academia had heard of it. Mr. Gardner, the writer whose CBD advocacy eventually inspired the 2011 summit at Ms. Police raids and federal prosecution of medical marijuana businesses were still common.

CBD 40
article thumbnail

Is Europe falling behind?

The Cannigma

In Europe, Murphy explains, cannabis products are held to the same standards of accountability and repeatability as other pharmaceuticals. What do those more pharmaceutical standards mean for patients? MSO: Obviously, every country is different but within Europe and certain rainy islands close to it. SM: I think it’s stability.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Epilepsy or epilepsies were mentioned in 39% of articles. Conclusions. Palliative care indications. Cancer pain.

article thumbnail

Cannabis in Israel, with Itai Rogel

The Cannigma

We have autism and epilepsy. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil. Because it’s not in the list and the doctors wants to give the prescription. Cannabis is given to oncology patients, palliative patients.